NovaBridge Biosciences (NBP) Share-based Compensation (2019 - 2025)

NovaBridge Biosciences (NBP) has reported Share-based Compensation for 5 consecutive years, with $3.9 million the latest figure, recorded in Q4 2025.

• Quarterly Share-based Compensation rose 378.76% year-over-year to $3.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25.2 million (down 43.67% YoY) and the FY2025 annual result came in at $22.8 million, up 660.0% from the prior year.
• Share-based Compensation declined to $3.9 million in Q4 2025 per NBP's latest filing, from $25.3 million in the prior quarter.
• Over the last five years, Share-based Compensation for NBP reached as high as $25.3 million in Q3 2025 and fell as low as $318000.0 in Q3 2024.
• A 3-year average of $7.5 million and a median of $2.9 million in 2025 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2024 — Share-based Compensation sank 93.48% — and 2025, when it jumped 7855.97%.
• Year by year, Share-based Compensation stood at $12.6 million in 2023, then plunged by 93.48% to $824000.0 in 2024, then soared by 378.76% to $3.9 million in 2025.
• According to Business Quant data, Share-based Compensation over the past three periods registered $3.9 million, $25.3 million, and $1.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.